Restriction Fragment Length Polymorphism Analysis of Mycobacterium tuberculosis Isolated from Taegu
1999; 19(5): 581-586
Ann Lab Med 2015; 35(5): 535-539
Published online September 1, 2015 https://doi.org/10.3343/alm.2015.35.5.535
Copyright © Korean Society for Laboratory Medicine.
Geehay Hong, M.D.1, Hyung-Doo Park, M.D.1, Rihwa Choi, M.D.1, Dong-Kyu Jin, M.D.2, Jae Hyeon Kim, M.D.3, Chang-Seok Ki, M.D.1, Soo-Youn Lee, M.D.1, Junghan Song, M.D.4, and Jong-Won Kim, M.D.1
Departments of Laboratory Medicine and Genetics1, Pediatrics2, and Medicine3, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; Department of Laboratory Medicine4, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
Correspondence to: Hyung-Doo Park
Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro Gangnam-gu, Seoul 135-710, Korea
Tel: +82-2-3410-0290
Fax: +82-2-3410-2719
E-mail: nayadoo@hanmail.net
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CYP21A2 mutation analysis of congenital adrenal hyperplasia (CAH) is challenging because of the genomic presence of a homologous CYP21A2 pseudogene and the significant incidence of pseudogene conversion and large deletions. The objective of this study was to accurately analyze the CYP21A2 genotype in Korean CAH patients using a combination of complementary methods. Long-range PCR and restriction fragment length polymorphism analyses were performed to confirm valid amplification of CYP21A2 and to detect large gene conversions and deletions before direct sequencing. Multiple ligation-dependent probe amplification (MLPA) analysis was conducted concurrently in 14 CAH-suspected patients and six family members of three patients. We identified 27 CYP21A2 mutant alleles in 14 CAH-suspected patients. The c.293-13A>G (or c.293-13C>G) was the most common mutation, and p.Ile173Asn was the second, identified in 25% and 17.9% of alleles, respectively. A novel frame-shift mutation of c.492delA (p.Glu 164Aspfs*24) was detected. Large deletions were detected by MLPA in 10.7% of the alleles. Mutation studies of the six familial members for three of the patients aided in the identification of haplotypes. In summary, we successfully identified CYP21A2 mutations using both long-range PCR and sequencing and dosage analyses. Our data correspond relatively well with the previously reported mutation spectrum analysis.
Keywords: CYP21A2, Pseudogene, Restriction fragment length polymorphism, Multiple ligation-dependent probe amplification, Korea